Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PCSK9 Inhibition After Heart Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03537742
Recruitment Status : Enrolling by invitation
First Posted : May 25, 2018
Last Update Posted : March 17, 2021
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
William Fearon, Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : September 2023
Estimated Study Completion Date : September 2023